"
Team:BIOSINT Mexico/finacial
From 2012e.igem.org
| Line 165: | Line 165: | ||
<p class="clr-1"><strong>Project evaluation.</strong></p> | <p class="clr-1"><strong>Project evaluation.</strong></p> | ||
</div> | </div> | ||
| - | <p> | + | <p><div style="text-align: center;"><img src="http://www.persoft.mx/biosint/images/Finanzas.png"/></div></p> |
</div> | </div> | ||
Latest revision as of 02:17, 28 October 2012
Initial investment.
Pre-operative expenses: The business incubator of the ITESM Campus Querétaro and the Parque Tecnológico have helped in the creation of Kuxtal Biotech, these institutions provided personal assessment as part of a pre-incubation process that have a total cost of 446.71 USD. Financial Plan: The required initial investment is $725,732.14 USD, to obtain this value, the following was considered: • $644,095.14 USD related to fixed assets, this includes all the laboratory equipment, and office equipment. • $6,561.54 USD related to deferred assets, this includes publicity, rent, installations, and preoperative expenses. • $75,075.46 USD related to circulating assets, this includes the necessary capital to be able to work for six months.
Financial indicators.
• The operation budget will be $63,114.69 USD, this includes salary wages for personal in charge of production and indirect expenses of production. • The administration budget will be $67,230.77 USD, this includes salary wages for administrative staff and the expenses related to this department. • The travel expenses budget for the salesmen staff will be $6,153.85USD. The equilibrium point was calculated as follows: (Total fixed costs)/(Sale price-Variable costs) Considering this, Kuxtal Biotech needs to sale 38,758.49 oligonucleotides with 20 bp of length to finance the expenses but without any earnings.
Project evaluation.
